Stockscreener 앱 받기
1.16
10.77%
-0.14
시간 외 거래:
1.18
0.02
+1.72%
전일 마감가:
$1.30
열려 있는:
$1.29
하루 거래량:
93,895
Relative Volume:
0.11
시가총액:
$2.75M
수익:
$29.78M
순이익/손실:
$-39.94M
주가수익비율:
-0.0187
EPS:
-61.9139
순현금흐름:
$-16.12M
1주 성능:
-19.44%
1개월 성능:
-35.20%
6개월 성능:
-95.32%
1년 성능:
-99.51%
1일 변동 폭
$1.11
$1.29
1주일 범위
$1.11
$1.51
52주 변동 폭
$1.11
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
명칭
22nd Century Group, Inc.
전화
716-270-1523
주소
8560 Main Street, Williamsville, NY
XXII을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
1.16 | 2.75M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-21 | 개시 | Alliance Global Partners | Buy |
| 2022-06-15 | 개시 | Craig Hallum | Buy |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2021-07-23 | 개시 | Cowen | Outperform |
| 2017-10-16 | 재확인 | Chardan Capital Markets | Buy |
| 2016-08-11 | 재확인 | Chardan Capital Markets | Buy |
모두보기
22nd Century Group, Inc. 주식(XXII)의 최신 뉴스
22nd Century Group, Inc. (NASDAQ:XXII) Q4 2024 Earnings Call Transcript - Insider Monkey
22nd Century reports $15.5 million loss for 2024; no net revenue from very-low-nicotine line - Winston-Salem Journal
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo
22nd Century outlines plans for VLN expansion and growth in 2025 - MSN
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Repositioning - GuruFocus.com
22nd Century Group Reports 2024 Financial Results - TipRanks
Earnings call transcript: 22nd Century Group Q4 2024 sees revenue drop - Investing.com Australia
Earnings call transcript: 22nd Century Group Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
22nd Century Group, Inc. SEC 10-K Report - TradingView
22nd Century Group reports annual financial results - Investing.com
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
22nd Century Group, Inc. Unveils 2025 Growth Strategy and Announces First VLN® Partner Brand with Smoker Friendly - Nasdaq
22nd Century Group reports annual financial results By Investing.com - Investing.com UK
22nd Century Group Earnings Reveal Major Transformation Plan as Losses Mount - StockTitan
22nd Century Group Earnings: CEO and CFO to Unveil Full Year Performance March 20 - StockTitan
22nd Century Group, Inc. to Host Webcast on March 20, 2025, for 2024 Financial Results and Future Plans - Nasdaq
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025 - The Manila Times
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly - GlobeNewswire
22nd Century Group expands VLN products with Smoker Friendly By Investing.com - Investing.com Australia
22nd Century Group expands VLN products with Smoker Friendly - Investing.com India
22nd Century Launches Reduced Nicotine Cigarettes Through Major Partnership - StockTitan
XXII stock plunges to 52-week low, touches $3.03 amid market rout - MSN
Weiss Ratings Reiterates “Sell (E)” Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
XXII stock plunges to 52-week low of $1.72 amid market challenges - Investing.com Australia
22nd Century regains compliance with the Nasdaq - MSN
XXII stock plunges to 52-week low of $2.98 amid market challenges - Investing.com Nigeria
XXII stock plunges to 52-week low of $2.98 amid market challenges By Investing.com - Investing.com South Africa
22nd Century Group (NASDAQ:XXII) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII) - Newsfile
22nd Century : FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast - Marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Down 63.8% in January - Defense World
XXII stock plunges to 52-week low, touches $3.03 amid market rout By Investing.com - Investing.com South Africa
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - Marketscreener.com
Exclusive: 22nd Century Group Unveils Strategic Vision at Emerging Growth ConferenceCEO Takes Center Stage - StockTitan
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 104,124 shares of common stock for holders - MSN
22nd Century Group, Inc. (XXII) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
1.63%
자본화:
|
볼륨(24시간):